Letter by Keidar and Gamliel-Lazarovich Regarding Article, “Effects of A Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial”
Author(s) -
Shlomo Keidar,
Aviva Gamliel-Lazarovich
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.080341
Subject(s) - aldosterone , medicine , aldosterone synthase , placebo , double blind , randomized controlled trial , placebo controlled study , pharmacology , blood pressure , endocrinology , pathology , renin–angiotensin system , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom